Clinical Trials on Lower Urinary Tract Predominant Storage Symptoms in Norway
Total 447 results
-
The Hospital of VestfoldSouth-Eastern Norway Regional Health AuthorityCompletedOveractive BladderNorway
-
Oslo University HospitalCompletedUrinary Incontinence | Pregnancy Complications | Urinary Stress IncontinenceNorway
-
Norwegian University of Science and TechnologySt. Olavs Hospital; Norwegian Fund for Postgraduate Training in Physiotherapy; Fund for Cancer ResearchCompletedUrinary IncontinenceNorway
-
Norwegian School of Sport SciencesTerminatedUrinary Incontinence | Stress Urinary IncontinenceNorway
-
Norwegian School of Sport SciencesThe Research Council of Norway; University Hospital, AkershusCompletedUrinary IncontinenceNorway
-
Norwegian University of Science and TechnologyOslo University Hospital; St. Olavs Hospital; Alesund HospitalCompletedUrinary Incontinence,StressNorway
-
Helse FonnaHelse Forde; Helse-Bergen HFUnknownDiabetes Mellitus | Urinary Incontinence | Weight LossNorway
-
Norwegian School of Sport SciencesCompletedUrinary Incontinence | Stress Urinary Incontinence | Pelvic Floor DisordersNorway
-
Oslo University HospitalSunnaas Rehabilitation HospitalCompletedUrinary Bladder, Overactive | Spinal Cord InjuriesNorway
-
Norwegian University of Science and TechnologySt. Olavs HospitalCompletedUrinary Incontinence | Uterine Prolapse | Fecal IncontinenceNorway
-
Norwegian School of Sport SciencesActive, not recruitingUrinary Incontinence | Overuse InjuryNorway
-
University Hospital of North NorwayHelse NordWithdrawnQuality of Life | Urinary Incontinence | Anal Incontinence | Sexual FunctionNorway
-
Oslo University HospitalEnrolling by invitationUrinary Incontinence | Sexual Dysfunction | Anal Incontinence | Obstetric Anal Sphincter InjuryNorway
-
Ostfold Hospital TrustSt. Olavs HospitalCompletedChronic Obstructive Pulmonary Disease | Urinary IncontinenceNorway
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedOveractive Bladder | Pharmacokinetics of Mirabegron | Neurogenic Detrusor OveractivityBelgium, Denmark, Norway, Poland, Serbia
-
PfizerCompletedOveractive BladderCzech Republic, Slovakia, United Kingdom, Sweden, Norway, Lithuania
-
Astellas Pharma Europe B.V.CompletedUrinary Bladder, OveractiveBelgium, United States, Brazil, Canada, Denmark, Former Serbia and Montenegro, Korea, Republic of, Mexico, Norway, Philippines, Poland, South Africa, Sweden, Turkey, Ukraine, United Kingdom
-
Medtronic - MITGCompletedUrinary Incontinence, Stress | Vaginal Vault Prolapse | Mixed IncontinenceUnited States
-
Astellas Pharma Europe B.V.CompletedUrinary Bladder, OveractiveBelgium, United States, Brazil, Canada, Denmark, Former Serbia and Montenegro, Korea, Republic of, Mexico, Norway, Philippines, Poland, South Africa, Sweden, Turkey, Ukraine, United Kingdom
-
Astellas Pharma Europe B.V.CompletedNeurogenic Detrusor OveractivityBelgium, Croatia, Turkey, Australia, Denmark, Israel, Jordan, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico, Norway, Philippines, Poland, Romania, Serbia, Slovakia, Taiwan
-
University of OsloCompleted
-
Sykehuset TelemarkOslo University HospitalActive, not recruitingQuality of Life | End Stage Renal Disease | End Stage Renal Failure on DialysisNorway
-
Oslo University HospitalNorwegian Institute of Public Health; University Hospital of North Norway; Ostfold... and other collaboratorsUnknownLower Respiratory Tract Infection | Pneumonia ChildhoodNorway
-
Boston Scientific CorporationCompletedUrinary IncontinenceUnited States
-
University of Oslo School of PharmacyOslo University HospitalCompleted
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveFrance, United Kingdom, Spain, Belarus, Belgium, Ukraine, Denmark, Greece, Russian Federation, Czech Republic, Netherlands, Germany, Hungary, Italy, Slovakia, Sweden, Norway
-
PfizerCompletedUrinary Bladder, OveractivePortugal, Spain, Turkey, Finland, Germany, Norway, Sweden, Slovakia, Italy, Austria, United Kingdom, Belgium, Denmark, Israel, Switzerland
-
Astellas Pharma IncCompletedOveractive Bladder | Detrusor OveractivityBelgium, Norway, Spain, Sweden, Italy, Czech Republic, Hungary, France, Canada, Germany, Austria, United Kingdom, Bulgaria, Russian Federation, United States, Poland, Slovakia, Turkey, Israel, Romania
-
PfizerCompletedUrinary Bladder, OveractiveAustralia, France, Colombia, Germany, Canada, Finland, Slovakia, Spain, Switzerland, Italy, Chile, Greece, Latvia, Norway, Poland, United Kingdom
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveFrance, United Kingdom, Belgium, Germany, Spain, Portugal, Greece, Russian Federation, Czech Republic, Poland, Hungary, Italy, Slovakia, Egypt
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveUnited States
-
University Hospital, AkershusUniversity of Oslo; Karolinska Institutet; St. Olavs Hospital; FolkehelsaUnknownUrinary Tract InfectionsNorway
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveUnited States
-
Helse Møre og Romsdal HFCompletedUrinary Tract InfectionsNorway
-
Sykehuset i Vestfold HFUniversity of OsloCompletedUrinary Tract Infections | PyelonephritisNorway
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedOveractive BladderPoland, United Kingdom, Germany, Spain, Netherlands, Belgium, Czech Republic, Italy, Norway, Hungary, Sweden, Denmark, Greece, France, Russian Federation
-
PfizerCompletedUrinary Bladder, OveractiveCanada, United States, Germany, Russian Federation, Czechia, Egypt, Bulgaria, Finland, Hungary, Korea, Republic of, Mexico, Poland, South Africa, Sweden, Ukraine
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveUnited States
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedOveractive Bladder (OAB)United States, Canada, Germany, Korea, Republic of, Spain, Turkey, Taiwan, Italy, Slovakia, Denmark, South Africa, United Kingdom, Mexico, Sweden, Norway
-
Astellas Pharma IncCompletedLower Urinary Tract Symptoms | Prostatic HyperplasiaFrance, Poland, Germany, Spain, Finland, Netherlands, Russian Federation, Czech Republic, Hungary, Norway, Denmark, Slovakia, Sweden, Austria, Portugal, United Kingdom
-
Ethicon, Inc.CompletedStress Urinary IncontinenceKorea, Republic of, United States, Canada, France, Germany, Singapore, United Kingdom
-
European Association of Urology Research FoundationBoston Scientific CorporationActive, not recruitingUrinary Incontinence, StressNetherlands, Spain, United Kingdom, Belgium, Germany, Finland, Norway, Czechia, Italy
-
PfizerCompletedOveractive BladderUnited States
-
PfizerCompletedOveractive BladderDenmark, United States, Canada, Costa Rica, Belgium, Czech Republic, Colombia, Germany, Hungary, Korea, Republic of, Spain, Chile, Taiwan, India, Brazil, Singapore, Greece, Hong Kong, Italy, Sweden, Poland, South Africa, Malaysia, Rom... and more
-
PfizerCompleted
-
Oslo University HospitalUniversity of Oslo; Helse Sor-OstActive, not recruiting
-
PfizerCompletedOveractive BladderKorea, Republic of, United States, Denmark, Germany, Canada, Hungary, Poland, France, United Kingdom, Slovakia, Sweden, Mexico, Czech Republic, Finland, Italy, Lithuania, Argentina, Chile, Colombia, Egypt, Greece, Norway, Philippines, Russian Federation and more
-
Astellas Pharma Europe B.V.CompletedUrologic Diseases | Urinary Bladder, Overactive | Urinary Bladder Diseases | Urological Manifestations | Signs and SymptomsBelarus, Belgium, Czechia, Denmark, Finland, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Slovakia, Spain, Sweden, Ukraine, United Kingdom